Roche Holding AG (TSX:ROG)

Market Cap	500.25B +45.6%
Revenue (ttm)	109.55B +1.5%
Net Income	22.27B +55.6%
EPS	27.74 +55.6%
Shares Out	n/a
PE Ratio	22.46
Forward PE	17.52
Dividend	n/a
Ex-Dividend Date	n/a

Volume	501
Average Volume	6,452
Open	28.29
Previous Close	28.20
Day's Range	28.29 - 28.31
52-Week Range	18.42 - 28.56
Beta	n/a
RSI	71.14
Earnings Date	Jan 29, 2026

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavir...

• Industry: Other
• Founded: 1896
• Employees: 103,249
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: ROG

Financial Performance

In 2025, Roche Holding AG's revenue was 63.36 billion, an increase of 1.54% compared to the previous year's 62.40 billion. Earnings were 12.88 billion, an increase of 55.61%.

Financial numbers in CHF